Exercise Intensity and Muscle Recovery in Statin Users

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30-65
SponsorRaffaele Mazzolari

About this trial

This study aims to investigate how different types and intensities of exercise affect muscle recovery in individuals taking statin medications compared to healthy controls. Statins are essential for cardiovascular prevention but are often associated with muscle-related side effects (SAMS), which can be exacerbated by physical activity.

The study will compare aerobic cycling (low muscular strain) with resistance training (RT) at increasing intensities (40%, 60%, and 80% of estimated 1-repetition maximum; e1RM). Researchers will measure markers of muscle damage, such as creatine kinase (CK) levels, and subjective recovery needs to determine which exercise modalities and intensities are best tolerated by statin users. The goal is to provide evidence for more individualized and safer exercise recommendations for this population.

Eligibility criteria

Qualifiers

Sedentary behavior (defined as < 1 hour of planned physical activity per week)

Low occupational physical activity

Age between 30 and 65 years

Non-smoker

Disqualifiers

BMI < 20 kg/m² or > 30 kg/m²

Smoking or smoking cessation < 1 year ago

Medical conditions or musculoskeletal issues that preclude eligibility for full physical effort or interfere with outcome measures

Medication (other than statins) that may interfere with physical exercise or outcome measures (assessment on a case-by-case basis during screening visit)

Trial design

Treatments tested in this trial

  • Dose-Escalation Exercise Protocol

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Raffaele Mazzolari

Lead sponsor

Medical University Innsbruck

Sponsor institution

Universitaet Innsbruck

Collaborator